CVS Caremark (CVS) Tops Q3 EPS by 3c; Adjusts FY11 EPS Below Views
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $101.57 +0.27%
EPS Growth %: +1.1%
Financial Fact:
Net revenues: 44.62B
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +1.1%
Financial Fact:
Net revenues: 44.62B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q3 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $26.7 billion versus the consensus estimate of $26.76 billion.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Nucor guides Q2 2026 earnings to $4.70-$4.80 per diluted share
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
